| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) | 
|---|
| 07/26/2007 | WO2006107207A3 A non-porous film for culturing cells  | 
| 07/26/2007 | WO2006078262A3 Methods of activation during nuclear transfer  | 
| 07/26/2007 | WO2006071746A3 Engineered dopamine neurons and uses thereof  | 
| 07/26/2007 | WO2006069036A3 Anti-il-12 antibodies, epitopes, compositions, methods and uses  | 
| 07/26/2007 | WO2005051998A3 Antibodies binding to a c-terminal fragment of apolipoprotein e  | 
| 07/26/2007 | WO2004003175A3 Process and materials for production of glucosamine and n-acetylglucosamine  | 
| 07/26/2007 | WO2003053220A3 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease  | 
| 07/26/2007 | WO2003023010A3 Sensory neuron receptors  | 
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof  | 
| 07/26/2007 | US20070174938 Corn root preferential promoters and uses thereof  | 
| 07/26/2007 | US20070174936 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics  | 
| 07/26/2007 | US20070174934 Method of selectively producing male or female sterile plants  | 
| 07/26/2007 | US20070174932 High amylose potato polysaccharide for use as renewable raw materials in food processing  | 
| 07/26/2007 | US20070174931 Methods for controlling gibberellin levels  | 
| 07/26/2007 | US20070174930 Soybean cultivar s050238  | 
| 07/26/2007 | US20070174929 Seeds produced by crossing soybean cultivar 5726085 with itself or with another soybean variety; insect resistance, herbicide resistance, disease resistance  | 
| 07/26/2007 | US20070174928 Soybean cultivar 5830261  | 
| 07/26/2007 | US20070174927 Transgenic expression constructs for vegetative plant tissue specific expression of nucleic acids  | 
| 07/26/2007 | US20070174926 Sperm factor oscillogenin  | 
| 07/26/2007 | US20070174924 Transgenic mice containing TRP gene disruptions  | 
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r  | 
| 07/26/2007 | US20070173889 Methods and apparatus for conversion of eukaryotic cells by application of electric and magnetic fields  | 
| 07/26/2007 | US20070172949 For use in systems for delivering and expressing desired genes and gene sequences; genetic engineering; gene therapy  | 
| 07/26/2007 | US20070172947 expanding Treg cells ; for type 1 diabetes; autoimmune disease, graft versus host disease, genetically inherited hematopoietic disorder, rheumatoid arthritis and multiple sclerosis  | 
| 07/26/2007 | US20070172946 Lineage specific cells and progenitor cells  | 
| 07/26/2007 | US20070172945 Bioreactor  | 
| 07/26/2007 | US20070172944 Cell Culture Tool  | 
| 07/26/2007 | US20070172938 Solid cellulosic culture medium and process for producing the same  | 
| 07/26/2007 | US20070172936 Purified active HCV NS2/3 protease  | 
| 07/26/2007 | US20070172928 Immunoglobulin chimeric monomer-dimer hybrids  | 
| 07/26/2007 | US20070172927 Immune complexes comprising proteins of human immunodeficiency virus type 2 (HIV-2), antibodies against proteins of HIV-2, methods and kits employing proteins of HIV-2, and immunogenic compositions comprising proteins of HIV-2  | 
| 07/26/2007 | US20070172918 Non aggregating fluorescent proteins and methods for using the same  | 
| 07/26/2007 | US20070172903 Microfluidic device for cell separation and uses thereof  | 
| 07/26/2007 | US20070172895 Flow cytometry; measuring binding efficiency of L104EA29YIg to CD86 or CD80 receptors by comparing the binding of non-competing anti-CD86 or CD80 monoclonal antibodies to CD86 or CD80 receptors; lysing blood sample and fixing leukocytes; measuring receptor expression; transplant rejection; immunology  | 
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide  | 
| 07/26/2007 | US20070172884 Monitoring sample for preferential particles; obtain sample, incubate on test column, wash column, incubate with probes, wash column, detect signals; using chemiluminescence labels acridinium dye; diagnosing diseases by detect nucleic acid has been used for diseases associated with abnormal gene products  | 
| 07/26/2007 | US20070172882 Identification of a family of secreted proteins in vascular endothelium  | 
| 07/26/2007 | US20070172879 Thermophilic DNA polymerases from thermoactinomyces vulgaris  | 
| 07/26/2007 | US20070172856 Materials and methods for treating chronic fibrotic diseases  | 
| 07/26/2007 | US20070172846 Methods for the Production and Purification of Adenoviral Vectors  | 
| 07/26/2007 | US20070172814 Method of Testing the Safety and Efficacy of a Drug  | 
| 07/26/2007 | US20070172812 Tissue equivalent for transplantation and method for producing same  | 
| 07/26/2007 | US20070172504 In vivo cell surface engineering  | 
| 07/26/2007 | US20070172493 12832, a novel human kinase-like molecule and uses thereof  | 
| 07/26/2007 | US20070172490 Leukocyte stimulation matrix  | 
| 07/26/2007 | US20070172487 Alpha-enolase specific antibody and method of use  | 
| 07/26/2007 | US20070172470 Phosphatase regulation of nucleic acid transcription  | 
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin  | 
| 07/26/2007 | US20070172466 Method of replenishing cells damaged by treatment for cancer  | 
| 07/26/2007 | US20070172465 Use of umbilical cord blood stem cells to treat ischemic event  | 
| 07/26/2007 | US20070172464 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same  | 
| 07/26/2007 | US20070172458 IL-6/IL-6R fusion protein  | 
| 07/26/2007 | US20070172455 Chimeric Interleukin-6 Soluble Receptor/Ligand Protein, Analogs Thereof and Uses Thereof  | 
| 07/26/2007 | US20070172448 Method for detecting the specificity of activated lymphocyte  | 
| 07/26/2007 | US20070172425 Testing cell cycle regulation effect of a compound using a hollow fibre cell implant  | 
| 07/26/2007 | DE102006005827B3 mRNA-Transfektion von adulten Progenitorzellen zur spezifischen Gewebsregeneration mRNA transfection of adult progenitor cells for tissue regeneration specific  | 
| 07/26/2007 | CA2643413A1 Composition and method to increase mammalian sperm function  | 
| 07/26/2007 | CA2637843A1 Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture  | 
| 07/26/2007 | CA2622671A1 Methods for controlling pests using rnai  | 
| 07/25/2007 | EP1811042A2 cDNA synthesis improvements  | 
| 07/25/2007 | EP1811035A1 Aspartic proteinase 2 (ASP2)  | 
| 07/25/2007 | EP1811034A2 Compounds and method for inhibiting axillary malodour  | 
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway  | 
| 07/25/2007 | EP1811026A1 Method of immunizing animal, composition for immunization, method of producing antibody, method of producing hybridoma and method of producing monoclonal antibody  | 
| 07/25/2007 | EP1811025A1 Mutated amyloid protein  | 
| 07/25/2007 | EP1811023A1 Gene expressed specifically in es cells and utilization of the same  | 
| 07/25/2007 | EP1811021A1 Novel carbonyl reductase, gene therefor and use thereof  | 
| 07/25/2007 | EP1811019A1 Seeding cells on porous supports  | 
| 07/25/2007 | EP1811018A1 Brain disposition marrow progenitor  | 
| 07/25/2007 | EP1810978A2 Group B streptococcus polypeptides nucleic acids and therapeutic composition and vaccines thereof  | 
| 07/25/2007 | EP1810691A2 Immunotherapy for reversing immune suppression  | 
| 07/25/2007 | EP1810685A1 Use of dimer-specific nuclear localisation signal peptides (dsNLS) derived from the STAT DNA binding domain  | 
| 07/25/2007 | EP1809750A2 Selection of host cells expressing protein at high levels  | 
| 07/25/2007 | EP1809748A2 Micrornas  | 
| 07/25/2007 | EP1809740A2 Cardiac stem cells  | 
| 07/25/2007 | EP1809739A2 Medium for growing human embryonic stem cells  | 
| 07/25/2007 | EP1809738A2 Compositions and methods for treating hyperproliferative disorders  | 
| 07/25/2007 | EP1809737A2 Mature dendritic cell compositions and methods for culturing same  | 
| 07/25/2007 | EP1809736A2 Cryopreservation of cells  | 
| 07/25/2007 | EP1809735A2 Methods of storing tissue matrices  | 
| 07/25/2007 | EP1809734A2 Disease treatment via developing non-syngeneic graft transplantation  | 
| 07/25/2007 | EP1809670A2 Irta-4 antibodies and their uses  | 
| 07/25/2007 | EP1809669A2 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents  | 
| 07/25/2007 | EP1809659A2 Transcription factors  | 
| 07/25/2007 | EP1809337A2 Chimeric vectors  | 
| 07/25/2007 | EP1809321A2 Adoptive immunotherapy with enhanced t lymphocyte survival  | 
| 07/25/2007 | EP1809094A2 Compositions and methods for modulating lignin of a plant  | 
| 07/25/2007 | EP1575998A4 Mammalian cell culture processes for protein production  | 
| 07/25/2007 | EP1558928B1 Medium and method for measuring the efficacy of a tumour therapy  | 
| 07/25/2007 | EP1503819A4 System and method for forming a non-ablative cardiac conduction block  | 
| 07/25/2007 | EP1370644A4 Materials and methods for the induction of premature chromosome condensation  | 
| 07/25/2007 | EP1350105B1 Immunoassays for anti-hcv antibodies  | 
| 07/25/2007 | EP1287144B1 Bacterial insecticidal proteins  | 
| 07/25/2007 | EP1141363B1 Target cell-specific adenoviral vectors containing e3 and methods of use thereof  | 
| 07/25/2007 | EP0943001B1 Heat stable mutants of starch biosynthesis enzymes  | 
| 07/25/2007 | EP0915968B1 Isolation, propagation, and directed differentiation of stem cells from central nervous system of mammals  | 
| 07/25/2007 | EP0824546B1 Angiostatin fragments and methods of use  | 
| 07/25/2007 | EP0759993B1 Dna sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1,4 glucans in plants, fungi and microorganisms  | 
| 07/25/2007 | EP0698092B1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same  | 
| 07/25/2007 | EP0676965B1 Method of reducing immunogenicity of variable region of antibodies  |